These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35927963)
1. Abrupt Discontinuation Versus Taper of Hydrocortisone in Patients With Septic Shock. Carabetta S; Allen B; Cannon C; Johnson T Ann Pharmacother; 2023 Apr; 57(4):375-381. PubMed ID: 35927963 [TBL] [Abstract][Full Text] [Related]
2. Abrupt versus gradual cessation of steroids in patients with septic shock. Sobolewski KA; Brophy A; Opsha Y; Zaid A; Mistry N J Crit Care; 2018 Dec; 48():198-202. PubMed ID: 30232056 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting. Ragoonanan D; Allen B; Cannon C; Rottman-Pietrzak K; Bello A Ann Pharmacother; 2022 Mar; 56(3):264-270. PubMed ID: 34109850 [TBL] [Abstract][Full Text] [Related]
4. Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study. Lock AE; Gutierrez GC; Hand EO; Barthol CA; Attridge RL Ann Pharmacother; 2023 Dec; 57(12):1375-1388. PubMed ID: 37026172 [TBL] [Abstract][Full Text] [Related]
5. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice. Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398 [TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes. Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197 [TBL] [Abstract][Full Text] [Related]
8. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective. Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552 [TBL] [Abstract][Full Text] [Related]
9. The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock. Zhang L; Gu WJ; Huang T; Lyu J; Yin H Anesth Analg; 2023 Oct; 137(4):850-858. PubMed ID: 37171987 [TBL] [Abstract][Full Text] [Related]
10. Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock. Lam SW; Sacha GL; Duggal A; Reddy AJ; Bauer SR Shock; 2021 Feb; 55(2):210-214. PubMed ID: 32842024 [TBL] [Abstract][Full Text] [Related]
11. Clinical Utilization of Stress Dose Hydrocortisone in Adult Patients With Septic Shock: A Retrospective Observational Study at a Large Academic Medical Center. Sacha GL; Chen AY; Palm NM; Wang X; Li M; Duggal A J Pharm Pract; 2023 Jun; 36(3):606-613. PubMed ID: 35156439 [No Abstract] [Full Text] [Related]
12. Controversies in Corticosteroid use for Sepsis. Long B; Koyfman A J Emerg Med; 2017 Nov; 53(5):653-661. PubMed ID: 28916121 [TBL] [Abstract][Full Text] [Related]
13. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Beale R; Janes JM; Brunkhorst FM; Dobb G; Levy MM; Martin GS; Ramsay G; Silva E; Sprung CL; Vallet B; Vincent JL; Costigan TM; Leishman AG; Williams MD; Reinhart K Crit Care; 2010; 14(3):R102. PubMed ID: 20525247 [TBL] [Abstract][Full Text] [Related]
14. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R; JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979 [TBL] [Abstract][Full Text] [Related]
15. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function. Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793 [TBL] [Abstract][Full Text] [Related]
16. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study. Bauer SR; Lam SW; Cha SS; Oyen LJ J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013 [TBL] [Abstract][Full Text] [Related]
17. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States. Bosch NA; Teja B; Wunsch H; Walkey AJ Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530 [No Abstract] [Full Text] [Related]
18. Vitamin C and Thiamine for Sepsis and Septic Shock. Mitchell AB; Ryan TE; Gillion AR; Wells LD; Muthiah MP Am J Med; 2020 May; 133(5):635-638. PubMed ID: 31469984 [TBL] [Abstract][Full Text] [Related]
19. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock. McDonnell E; Collins R; Hernandez M; Brown ART J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Early Versus Late Adjunctive Vasopressin and Corticosteroids in Patients With Septic Shock. Alshehri AM; Kovacevic MP; Dube KM; Lupi KE; DeGrado JR Ann Pharmacother; 2024 May; 58(5):461-468. PubMed ID: 37542417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]